SCNI CIK: 1611747

Scinai Immunotherapeutics Ltd.

  • Israel
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
17.8
FY22:
14.4
FY23:
5.45
FY24:
2.39
FY25:
2.05
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.2
FY22:
12.7
FY23:
12.0
FY24:
11.1
FY25:
9.57
Total assets
Change from FY21 to FY25
millions USD
FY21:
32.0
FY22:
27.1
FY23:
17.5
FY24:
13.4
FY25:
11.6

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
2.44
FY22:
2.34
FY23:
1.78
FY24:
1.81
FY25:
1.59
(negative)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
26.5
FY23:
20.3
FY24:
1.67
FY25:
1.94
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.98
FY22:
−1.76
FY23:
−4.57
FY24:
9.98
FY25:
8.10
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
27.1
FY23:
17.5
FY24:
13.4
FY25:
11.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data